[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$advms
ADVM sees strong buy recommendations due to potential gene therapy breakthroughs. The company's flagship product ADVM-022 is on the fast track for wet AMD.
About $advms
A biotechnology company.
Engagements: X #
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: X
1-Year High: XX on 2025-06-25
1-Year Low: X on 2025-07-20
| Social Network | X |
|---|---|
| Engagements | X |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-06-25
1-Year Low: X on 2025-06-25
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $advms in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-06-25
1-Year Low: X on 2025-06-25
Top assets mentioned In the posts about $advms in the last XX hours
Adverum Biotechnologies, Inc. Common Stock (ADVM) Advanced Micro Devices (AMD)
Top topics mentioned In the posts about $advms in the last XX hours
$100b, 10x, $advm, advanced micro devices
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ADVM: Gene Therapy Dark Horse with 10X Upside & FDA Catalyst Pioneering eye disease cures $ADVM's flagship ADVM-022 scored FDA Fast Track for wet AMD ($100B market). Analysts scream "Strong Buy""
@Odocsllough on X 2025-07-18 12:26:22 UTC XXX followers, XX engagements